Reported 4 days ago
U.S. equities experienced a dip at midday as 2024 trading winds down, with Moderna being the top performer after being labeled 'too cheap' by Barron's. Verisign saw gains following a stake increase by Berkshire Hathaway, while Tesla faced a potential four-day losing streak on delivery report concerns. Dave's shares fell sharply due to changes in its fee schedule amid legal troubles, and Sangamo Therapeutics lost half its value after Pfizer withdrew from a partnership.
Source: YAHOO